•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
California Resources Starts First CO2 Injection at CCS Facility
American Cancer Society Recommends Guardant Health's Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
California Resources Corporation Achieves First CO₂ Injection at Carbon TerraVault I, a Major Milestone for Carbon Management in California
California Resources Corporation Achieves First CO₂ Injection at Carbon TerraVault I, a Major Milestone for Carbon Management in California
Is California Resources (CRC) Stock Outpacing Its Oils-Energy Peers This Year?
California Resources Q1 Earnings Beat on Strong Oil Prices
California Resources Q1 Earnings Call Highlights
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
California Resources Corporation (CRC) Q1 2026 Earnings Call Transcript
California Resources Corporation (CRC) Q1 Earnings and Revenues Top Estimates
California Resources Corporation Reports First Quarter 2026 Financial and Operating Results
California Resources Corporation Reports First Quarter 2026 Financial and Operating Results
Carbon TerraVault Provides First Quarter 2026 Update
Permian Resources (PR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Earnings Preview: California Resources Corporation (CRC) Q1 Earnings Expected to Decline
Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?